Why the study?
Long-term antidepressant use beyond guideline recommendations risks adverse events and costs, requiring an understanding of patients' views on antidepressants and discontinuation.
What are patients' experiences, views, barriers, and facilitators regarding the discontinuation of long-term antidepressants in primary care?
What are patients' experiences, views, barriers, and facilitators regarding the discontinuation of long-term antidepressants in primary care?
Discontinuation of long-term antidepressants is complex for patients due to fear of relapse and low coping confidence, requiring active GP support and non-pharmacological approaches.
May require proactive GP support during tapering; extends qualitative insights but leaves optimal strategies open.
BACKGROUND AND AIM: The rise in long-term antidepressant use is concerning. Long-term antidepressant (AD) use, much longer than recommended by guidelines, can result in risk of adverse events and generate unnecessary costs. In order to mitigate these risks, patients views about their antidepressants and how to discontinue need to be taken into account. We aimed to explore patients' experiences and views of discontinuing long-term AD, barriers and facilitators of discontinuation and required support. METHODS: Semi-structured face to face interviews were conducted with 14 patients with long-term AD use in primary care. Interviews were analysed thematically. RESULTS: Participants describe various perceptions about discontinuation. There is fear of returning to their depression, even in those who were ambivalent about the effectiveness and safety of AD continuation. Participants describe low confidence in their own coping resources, fear of stress, and previous negative experiences with stopping. This enhances their perception of AD dependence. Participants indicate the importance of the support of their GP and their social network to help them withdraw. CONCLUSION: Discontinuation of long-term antidepressants is a complex issue for patients. More awareness of the lack of evidence and the potential risks of long-term AD continuation is required. By raising the issue and offering support during discontinuation GPs can help their patients stop AD. A greater focus on non-pharmacological approaches of depression in primary care is needed to reduce unnecessary AD use.
No takes yet. Share an insight, caveat, or question.
A 2022 study studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: